1. 250 Million Patient-Days with Tenoxicam

   • H. Fenner

   OriginalPaper 26 October 2012 Pages: 1 - 6

2. Tenoxicam

   • D. E. Caughey

   Short Communication 26 October 2012 Pages: 7 - 8

3. Clinical Experience with Tenoxicam in Latin America

   • Eliseo García-Oyola
   • Javier Orozco-Alcalá

   OriginalPaper 26 October 2012 Pages: 9 - 14

4. Wrist Actigraphic Measurements in Patients with Rheumatoid Arthritis

   • P. Lavie
   • Margalit Lorber
   • Yehuda Sharf

   OriginalPaper 26 October 2012 Pages: 15 - 21

5. Premarketing Risk to Benefit Study of Tenoxicam

   • P. Netter
   • B. Bannwarth
   • J. L. Vienne

   OriginalPaper 26 October 2012 Pages: 22 - 30

6. Tenoxicam

   • W. Katzmann

   OriginalPaper 26 October 2012 Pages: 31 - 37

7. General Discussion

   • C. G. Barnes

   OriginalPaper 26 October 2012 Pages: 38 - 39

8. Tenoxicam Versus Piroxicam in Rheumatoid Arthritis

   • C. Amante

   Short Communications 26 October 2012 Pages: 40 - 41

9. A Double-Blind Comparative Clinical Study of Tenoxicam Versus Diclofenac Retard in Extra-Articular Inflammation

   • R. Arinoviche
   • M. Arriagada

   Short Communications 26 October 2012 Pages: 41 - 42

10. The Gastroduodenal Tolerance of Tenoxicam and Diclofenac

    • H. G. Dammann
    • M. Dreyer
    • J. Simon-Schultz

    Short Communications 26 October 2012 Pages: 43 - 44

11. Short Term Efficacy of Tenoxicam in Active Rheumatic Conditions

    • G. Dilşen
    • N. Dilşen

    Short Communications 26 October 2012 Pages: 44 - 45

12. Efficacy of Tenoxicam in the Treatment of Patients with Rheumatoid Arthritis

    • Z. Domljan
    • L. Pučar
    • M. Gošev

    Short Communications 26 October 2012 Pages: 45 - 47

13. Tenoxicam Versus Diclofenac Retard in Osteoarthritis of the Knee

    • A. Dunky
    • U. Fasching
    • F. Singer

    Short Communications 26 October 2012 Pages: 47 - 48

14. Clinical Effects of Tenoxicam in Degenerative and Rheumatoid Arthritis

    • N. H. Kim
    • M. H. Han
    • J. C. Choi

    Short Communications 26 October 2012 Pages: 48 - 49

15. Double-Blind Evaluation of the Safety and Efficacy of Tenoxicam (Tilcotil®) Compared with Piroxicam in Patients with Degenerative Arthritis

    • H. K. Lee
    • M. S. Chung
    • F. Y. I. Lee

    Short Communications 26 October 2012 Pages: 50 - 51

16. Comparison of the Analgesic Effect of Tenoxicam After Oral or Intramuscular Administration

    • V. Listrat
    • M. Dougados
    • B. Amor

    Short Communications 26 October 2012 Pages: 51 - 52

17. Tenoxicam Versus Diclofenac in Patients with Ankylosing Spondylitis

    • F. Mayrhofer
    • H. Bröli
    • N. Thumb

    Short Communications 26 October 2012 Pages: 52 - 53

18. Efficacy and Tolerability of Tenoxicam Versus Diclofenac in Rheumatoid Arthritis

    • F. Singer
    • H. Bouda
    • J. Smolen

    Short Communications 26 October 2012 Pages: 54 - 55